Literature DB >> 11272330

Improved high performance liquid chromatographic analysis of omeprazole in human plasma.

K H Yuen1, W P Choy, H Y Tan, J W Wong, S P Yap.   

Abstract

A simple high-performance liquid chromatographic method was developed for the determination of omeprazole in human plasma. Omeprazole and the internal standard, chloramphenicol, were extracted from alkalinized plasma samples using dichloromethane. The mobile phase was 0.05 M Na2HPO4-ACN (65:35, v/v) adjusted to pH 6.5. Analysis was run at a flow rate of 1.0 ml/min at a detection wavelength of 302 nm. The method was specific and sensitive with a detection limit of 2.5 ng/ml at a signal-to-noise ratio of 4:1. The limit of quantification was set at 5 ng/ml. The calibration curve was linear over a concentration range of 5-1280 ng/ml. Mean recovery value of the extraction procedure was about 96%, while the within and between day coefficient of variation and percent error values of the assay method were all less than 14%.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11272330     DOI: 10.1016/s0731-7085(00)00473-8

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians.

Authors:  J Rosemary; C Adithan; N Padmaja; C H Shashindran; N Gerard; R Krishnamoorthy
Journal:  Eur J Clin Pharmacol       Date:  2005-01-21       Impact factor: 2.953

2.  Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.

Authors:  Céline Vidaillac; Jean Guillon; Corinne Arpin; Isabelle Forfar-Bares; Boubakar B Ba; Jean Grellet; Stéphane Moreau; Daniel-Henri Caignard; Christian Jarry; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

3.  Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype.

Authors:  Hai-Ling Qiao; Yu-Rong Hu; Xin Tian; Lin-Jing Jia; Na Gao; Li-Rong Zhang; Yu-Zhong Guo
Journal:  Eur J Clin Pharmacol       Date:  2006-01-10       Impact factor: 2.953

4.  Complexity in estimation of esomeprazole and its related impurities' stability in various stress conditions in low-dose aspirin and esomeprazole magnesium capsules.

Authors:  Palavai Sripal Reddy; Kishore Kumar Hotha; Shakil Sait
Journal:  Sci Pharm       Date:  2013-02-18

5.  A Validated HPTLC Method for Determination of Ondansetron in Combination with Omeprazole or Rabeprazole in Solid Dosage Form.

Authors:  P B Raval; Manisha Puranik; S J Wadher; P G Yeole
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.